tyrosine has been researched along with Pulmonary Hypertension in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.33) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 9 (37.50) | 29.6817 |
| 2010's | 11 (45.83) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Baumgart-Vogt, E; Bednorz, M; Brandes, RP; Buchmann, G; Dorfmüller, P; Eichstaedt, C; Fysikopoulos, A; Gattenlöhner, S; Geiszt, M; Ghofrani, HA; Gredic, M; Grimminger, F; Grünig, E; Günther, A; Hadzic, S; Hecker, A; Hecker, M; Henneke, I; Hinderhofer, K; Jaksch, P; Kanbagli, ZI; Karnati, S; Klepetko, W; Knoepp, F; Kojonazarov, B; Kraut, S; Müller, N; Padberg, W; Pak, O; Parajuli, N; Pichl, A; Rezende, F; Scheibe, S; Schermuly, RT; Schröder, K; Seeger, W; Seimetz, M; Sommer, N; Veith, C; Vogelmeier, CF; Weissmann, N; Wilhelm, J; Wittig, I; Wu, CY | 1 |
| Godo, S; Ikumi, Y; Ito, A; Kajitani, S; Saito, H; Sato, S; Shimokawa, H; Shiroto, T; Tanaka, S | 1 |
| Fujita, T; Kawakami-Mori, F; Mu, S; Ogura, S; Shimosawa, T; Shirai, M; Sonobe, T; Uetake, Y; Wang, H; Yatomi, Y; Yoshida, K | 1 |
| Almudéver, P; Cogolludo, A; Cortijo, J; De Diego, A; Milara, J; Perez-Vizcaino, F; Serrano-Mollar, A; Xaubet, A | 1 |
| Bálint, Z; Dahal, BK; Kwapiszewska, G; Murmann, K; Schermuly, RT; Seeger, W; Veith, C; Weissmann, N; Wygrecka, M; Zakrzewicz, D | 1 |
| Aggarwal, S; Black, SM; Desai, J; Fields, T; Jonigk, D; Kangath, A; Ludewig, B; Qu, N; Rafikov, R; Rafikova, O; Sharma, S; Yuan, JX | 1 |
| Chovanec, M; Hampl, V; Herget, J; Novotná, J; Vízek, M; Wilhelm, J | 1 |
| Malik, AB; Zhao, YY | 1 |
| Arroliga, AC; Comhair, SA; Dostanic-Larson, I; Dweik, RA; Erzurum, SC; Kaneko, FT; Masri, FA | 1 |
| Domarski, S; Fattman, C; Klemm, D; Majka, S; Nozik-Grayck, E; Stenmark, KR; Van Rheen, Z | 1 |
| Ivanovska, J; Jankov, RP; Kantores, C; Lee, AH; Lewis, P; McNamara, PJ; Tanswell, AK; Van Vliet, T; Xu, EZ | 1 |
| Bolton, S; Cadogan, EB; Churg, A; Mallinder, PR; Maltby, J; Marshall, CV; Sin, DD; Soars, MG; Thain, K; Wright, JL; Zhou, S | 1 |
| Czech, L; Farrow, KN; Gugino, SF; Lakshminrusimha, S; Russell, JA; Soares, F; Steinhorn, RH; Wedgwood, S | 1 |
| Hu, H; Huang, ZS; Jiang, L; Jiang, YZ; Liu, P; Ouyang, HW; Song, XH; Zeng, CL; Zhu, LJ | 1 |
| Churg, A; Wright, JL; Zhou, S | 1 |
| Bowers, R; Cool, C; Flores, SC; Hopken, MW; Murphy, RC; Tuder, RM; Voelkel, NF | 1 |
| Knowles, JA; Morse, JH; Wong, WK | 1 |
| Banasová, A; Bíbová, J; Hampl, V; Herget, J; Hnilicková, O; Lachmanová, V; Miková, D; Uhlík, J | 1 |
| Davis, JM; Horowitz, S; Kazzaz, JA; Narula, P; Robbins, CG; Xu, J | 1 |
| Belcastro, R; Copland, I; Frndova, H; Hoidal, JR; Jankov, RP; Luo, X; Lye, SJ; Post, M; Tanswell, AK | 1 |
| Beckman, JS | 1 |
| Bekker, JM; Black, SM; Fineman, JR; McMullan, DM; Wedgwood, S | 1 |
| Blomfield, J; Farrar, JF | 1 |
| Hauge, A; Melmon, KL | 1 |
1 review(s) available for tyrosine and Pulmonary Hypertension
| Article | Year |
|---|---|
A novel insight into the mechanism of pulmonary hypertension involving caveolin-1 deficiency and endothelial nitric oxide synthase activation.
Topics: Animals; Caveolin 1; Cyclic GMP-Dependent Protein Kinases; Enzyme Activation; Humans; Hypertension, Pulmonary; Mice; Nitric Oxide Synthase Type III; Tyrosine | 2009 |
23 other study(ies) available for tyrosine and Pulmonary Hypertension
| Article | Year |
|---|---|
NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Emphysema; Humans; Hypertension, Pulmonary; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Peroxynitrous Acid; Pulmonary Disease, Chronic Obstructive; Signal Transduction; Superoxides; Tobacco Smoke Pollution; Tyrosine | 2020 |
Important role of endothelium-dependent hyperpolarization in the pulmonary microcirculation in male mice: implications for hypoxia-induced pulmonary hypertension.
Topics: Animals; Biological Factors; Disease Models, Animal; Endothelium, Vascular; Hypertension, Pulmonary; Hypoxia; Male; Membrane Potentials; Mice, Inbred C57BL; Microcirculation; Nitric Oxide; Pulmonary Artery; Pulmonary Circulation; Signal Transduction; Tyrosine; Vascular Remodeling; Vasodilation; Vasodilator Agents | 2018 |
Oxidative stress augments pulmonary hypertension in chronically hypoxic mice overexpressing the oxidized LDL receptor.
Topics: Animals; Antioxidants; Chronic Disease; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Lipoproteins, LDL; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; NADPH Oxidases; Oxidative Stress; Pulmonary Artery; Reactive Oxygen Species; Scavenger Receptors, Class E; Signal Transduction; Tyrosine; Up-Regulation; Ventricular Function, Right; Ventricular Pressure | 2013 |
Role of tetrahydrobiopterin in pulmonary vascular remodelling associated with pulmonary fibrosis.
Topics: Aged; Alcohol Oxidoreductases; Animals; Biopterins; Chromatography, High Pressure Liquid; Disease Models, Animal; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; GTP Cyclohydrolase; Humans; Hypertension, Pulmonary; Immunohistochemistry; Male; Middle Aged; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Pulmonary Artery; Pulmonary Fibrosis; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Tyrosine | 2013 |
Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment.
Topics: Active Transport, Cell Nucleus; Animals; Antihypertensive Agents; Apoptosis; Becaplermin; Benzamides; Cell Adhesion; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Humans; Hypertension, Pulmonary; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Imatinib Mesylate; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Paxillin; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-sis; Pulmonary Artery; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; RNA Interference; Signal Transduction; Time Factors; Transfection; Tyrosine; Vascular Remodeling | 2014 |
Redox regulation of epidermal growth factor receptor signaling during the development of pulmonary hypertension.
Topics: Animals; ErbB Receptors; Humans; Hypertension, Pulmonary; Monocrotaline; Muscle, Smooth, Vascular; Oxidation-Reduction; Oxidative Stress; Phosphorylation; Protein Multimerization; Pulmonary Artery; Rats; Signal Transduction; Tyrosine | 2016 |
Hypercapnia attenuates hypoxic pulmonary hypertension by inhibiting lung radical injury.
Topics: Animals; Blood Pressure; Chronic Disease; Disease Models, Animal; Hypercapnia; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Lung Injury; Male; Oxidative Stress; Pulmonary Artery; Rats; Rats, Wistar; Time Factors; Tyrosine | 2009 |
Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension.
Topics: Adult; Antioxidants; Blood Pressure; Bronchi; Bronchoalveolar Lavage Fluid; Female; Humans; Hypertension, Pulmonary; Lung; Male; Models, Biological; Nitric Oxide; Respiratory Mucosa; Superoxide Dismutase; Systole; Tyrosine | 2008 |
Lung extracellular superoxide dismutase overexpression lessens bleomycin-induced pulmonary hypertension and vascular remodeling.
Topics: Animals; Bleomycin; Cell Proliferation; Early Growth Response Protein 1; Extracellular Space; Gene Expression Regulation; Humans; Hypertension, Pulmonary; Lung; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nitric Oxide Synthase Type III; Nitrosation; Oxidation-Reduction; Pulmonary Artery; Pulmonary Fibrosis; Stress, Physiological; Superoxide Dismutase; Transforming Growth Factor beta; Tyrosine | 2011 |
Peroxynitrite mediates right-ventricular dysfunction in nitric oxide-exposed juvenile rats.
Topics: Administration, Inhalation; Animals; Animals, Newborn; Apoptosis; Disease Models, Animal; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Metalloporphyrins; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Peroxynitrous Acid; Rats; Tyrosine; Vascular Resistance; Ventricular Dysfunction, Right | 2010 |
Late intervention with a myeloperoxidase inhibitor stops progression of experimental chronic obstructive pulmonary disease.
Topics: Airway Remodeling; Animals; Dinoprost; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Female; Guinea Pigs; Hypertension, Pulmonary; Inflammation; Lung; Oxidative Stress; Peroxidase; Pulmonary Disease, Chronic Obstructive; Purines; Smoking; Thiones; Thioxanthenes; Tyrosine | 2012 |
Apocynin improves oxygenation and increases eNOS in persistent pulmonary hypertension of the newborn.
Topics: Acetophenones; Animals; Animals, Newborn; Biopterins; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Endothelium, Vascular; Hypertension, Pulmonary; Lung; NADPH Oxidases; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Norepinephrine; Pulmonary Artery; Reactive Oxygen Species; Sheep; Superoxides; Tyrosine; Vasoconstriction; Vasodilation | 2012 |
Platelet-mediated mesenchymal stem cells homing to the lung reduces monocrotaline-induced rat pulmonary hypertension.
Topics: Animals; Antibodies; Blood Platelets; Blood Pressure; Bone Marrow Cells; Familial Primary Pulmonary Hypertension; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Lung; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Monocrotaline; P-Selectin; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Rats, Sprague-Dawley; Tirofiban; Tyrosine | 2012 |
Pulmonary hypertension and vascular oxidative damage in cigarette smoke exposed eNOS(-/-) mice and human smokers.
Topics: Animals; Biomarkers; Humans; Hypertension, Pulmonary; Lung; Mice; Mice, Knockout; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Smoking; Tyrosine | 2012 |
Oxidative stress in severe pulmonary hypertension.
Topics: Arachidonic Acids; Guanosine; Humans; Hypertension, Pulmonary; Lung; Oxidative Stress; Severity of Illness Index; Superoxide Dismutase; Tyrosine | 2004 |
Bone morphogenetic protein receptor type II C-terminus interacts with c-Src: implication for a role in pulmonary arterial hypertension.
Topics: Bone Morphogenetic Protein Receptors, Type II; Bone Morphogenetic Proteins; Cells, Cultured; CSK Tyrosine-Protein Kinase; Cytoplasm; Humans; Hypertension, Pulmonary; Immunoprecipitation; Lung; Mutation; Myocytes, Smooth Muscle; Phosphorylation; Protein Structure, Tertiary; Protein-Tyrosine Kinases; src-Family Kinases; Two-Hybrid System Techniques; Tyrosine | 2005 |
Pulmonary vascular iNOS induction participates in the onset of chronic hypoxic pulmonary hypertension.
Topics: Administration, Oral; Animals; Chronic Disease; Dose-Response Relationship, Drug; Enzyme Inhibitors; Exhalation; Hypertension, Pulmonary; Hypoxia; Lung; Lysine; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Pulmonary Artery; Rats; Rats, Wistar; Time Factors; Tyrosine | 2006 |
Synergistic cytotoxicity from nitric oxide and hyperoxia in cultured lung cells.
Topics: Cells, Cultured; Drug Synergism; Endothelium, Vascular; Humans; Hypertension, Pulmonary; Lung; Microcirculation; Nitric Oxide; Oxygen; Pulmonary Alveoli; Tyrosine | 1998 |
Gadolinium chloride inhibits pulmonary macrophage influx and prevents O(2)-induced pulmonary hypertension in the neonatal rat.
Topics: Animals; Animals, Newborn; Bronchopulmonary Dysplasia; Cell Movement; Cells, Cultured; Dinoprost; Endothelin-1; F2-Isoprostanes; Gadolinium; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Infant, Newborn; Macrophages, Alveolar; Oxygen; Rats; Rats, Sprague-Dawley; Tyrosine | 2001 |
-OONO: rebounding from nitric oxide.
Topics: Administration, Inhalation; Animals; Endothelium, Vascular; Epoprostenol; Hemoglobins; Humans; Hydroxyl Radical; Hypertension, Pulmonary; Nitrates; Nitric Oxide; Nitrogen Dioxide; Oxidation-Reduction; Pneumonia; Prostaglandin H2; Prostaglandins H; Signal Transduction; Superoxides; Tyrosine | 2001 |
Role for endothelin-1-induced superoxide and peroxynitrite production in rebound pulmonary hypertension associated with inhaled nitric oxide therapy.
Topics: Administration, Inhalation; Animals; Blotting, Western; Cells, Cultured; Dioxoles; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Activation; Humans; Hypertension, Pulmonary; Lung; Microscopy, Fluorescence; Muscle, Smooth, Vascular; Nitrates; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Pulmonary Artery; Receptor, Endothelin A; Secondary Prevention; Sheep; Superoxides; Tyrosine | 2001 |
The fluorescent properties of maturing arterial elastin.
Topics: Adolescent; Adult; Age Factors; Aged; Aorta; Child; Child, Preschool; Elastin; Female; Fluorescence; Formates; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; Infant; Infant, Newborn; Male; Middle Aged; Pulmonary Artery; Pulmonary Valve Stenosis; Tyrosine | 1969 |
Role of histamine in hypoxic pulmonary hypertension in the rat. II. Depletion of histamine, serotonin, and catecholamines.
Topics: Animals; Blood Platelets; Catecholamines; Guanethidine; Histamine; Hypertension, Pulmonary; In Vitro Techniques; Lung; p-Methoxy-N-methylphenethylamine; Pulmonary Artery; Pulmonary Circulation; Pulmonary Veins; Rats; Reserpine; Serotonin; Tyrosine | 1968 |